Genesis IBRC India

Genesis IBRC India EBIT per Share

Delisted·Sep 16, 2026

The EBIT per Share of Genesis IBRC India (514336.BO) as of Nov 3, 2026 is -0.12 INR. In the previous year, EBIT per Share was -2.92 INR — a change of -95.72% (higher).

EBIT per Share

-0.12INR

YoY

-95.72%

Last updated:

EBIT per Share of Genesis IBRC India is 2025 -0.12 INR. EBIT per Share of Genesis IBRC India was 2024 -2.92 INR. It decreases by -95.72% higher compared to the previous year.

The Genesis IBRC India EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2014
-0.26 INR
Jan 1, 2015
-0.28 INR
Jan 1, 2016
0.26 INR
Jan 1, 2017
0.00 INR
Jan 1, 2018
0.07 INR
Jan 1, 2023
-0.11 INR
Jan 1, 2024
-2.92 INR
Jan 1, 2025
-0.12 INR
The Genesis IBRC India EBIT per Share history
YEAREBIT per ShareYoY
-0.12INR-95.72%
-2.92INR+2,663.83%
-0.11INR-253.72%
0.07INR+5,365.03%
0.00INR-99.52%
0.26INR-195.64%
-0.28INR+6.21%
-0.26INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genesis IBRC India Stock analysis

What does Genesis IBRC India do? Genesis IBRC India Ltd. generates revenue through the manufacturing and sale of pro-biotic products for aquaculture and fisheries, including GENPRO-WAT, PRO-VIBSOL, AMMONO-GEN, GENLACT, GROWFAST-GEN, and GEN-POND CLEAN. The company provides formulation research and development services for agriculture, aquaculture, poultry, and veterinary bio formulations, offering need-based product design, land labs, and consultation services. Its primary customers are businesses in aquaculture, fisheries, agriculture, and veterinary sectors seeking specialized pro-biotic solutions and R&D support. The company's product portfolio targets water and soil pro-biotics, vibrio controllers, ammonia and nitrites reducers, gut and intestinal pro-biotics, single cell protein, and fast decomposers. These solutions are designed to address specific challenges in aquatic and agricultural environments, such as water quality management and animal health. The firm's R&D services cater to clients requiring tailored bio-formulation development and technical expertise for their operational needs. Genesis IBRC India is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genesis IBRC India stock

EBIT per Share of Genesis IBRC India is -0.12 INR in 2025.

EBIT per Share of Genesis IBRC India changed from -2.92 INR to -0.12 INR, representing a -95.72% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Genesis IBRC India since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Genesis IBRC India

All Key Metrics — Genesis IBRC India